$39M sweet spot round size
Most of their 21 investments are in rounds between $18M and $60M
1993
Undisclosed raised $60M on December 1, 2022
Investors: ARCH Venture Partners, GV, Cambridge Innovation Capital plc and Evotec
Cajal Neuroscience raised $96M on November 29, 2022
Investors: Lux Capital, Bristol-Myers Squibb, UK, Two Sigma Ventures, The Column Group, Dolby Family Ventures and Evotec
Tubulis GmbH raised $63M on May 3, 2022
Investors: Andera Partners, OCCIDENT, Bayern Kapital GmbH, High-Tech Gründerfonds, BioMedPartners, coparion, Seventure Partners, FundPlus and Evotec
Centauri Therapeutics Limited raised $33M on February 16, 2022
Investors: Novo Holdings, Animatrix Founders LLP and Evotec
IMIDomics Inc. raised undisclosed on February 15, 2022
Investors: Evotec
Topas Therapeutics GmbH raised $21M on July 29, 2021
Investors: Gimv, EMBL Ventures, Epidarex Capital, BioMedPartners, Vesalius Biocapital and Evotec
OXVax Ltd raised undisclosed on April 21, 2021
Investors: Evotec
Exscientia raised $40M on March 4, 2021
Investors: Novo Holdings, Bristol-Myers Squibb, UK and Evotec
ARGOBIO raised $60M on March 2, 2021
Investors: Evotec
Autobahn Labs, Inc. raised undisclosed on June 24, 2020
Investors: Samsara BioCapital and Evotec
$295M
from 8 investors over 8 rounds
Evotec raised $6.6M on March 24, 2023
Investors: Bill & Melinda Gates Foundation
Evotec raised $160M on February 10, 2023
Investors: European Investment Bank
Evotec raised $8.5M on January 3, 2022
Investors: Federal Ministry of Education and Research, Germany
Evotec raised $18M on December 16, 2021
Investors: Bill & Melinda Gates Foundation
Evotec raised undisclosed on October 19, 2020
Investors: Bill & Melinda Gates Foundation
Evotec raised $295M on October 13, 2020
Investors: Novo Holdings
Evotec raised $2.9M on August 11, 2020
Investors: CARB-X
Evotec raised $90M on September 8, 2017
Investors: European Investment Bank